Professor Elizabeth Davis has had a career of integrating clinical care and diabetes research with the goal of improving outcomes for youth with diabetes. She is Head of the Department of Endocrinology at Perth Children’s Hospital (PCH) and co-directs the Children’s Diabetes Centre, a Breakthrough T1D Global Centre of Excellence, at the Kids Research Institute Australia. Professor Davis is a past President of the Australasian Paediatric Endocrine Group. She currently leads the Australasian hub of SWEET, an international paediatric diabetes initiative with the goal of improving outcomes for children with diabetes globally.

Rachelle Ward (PhD, 2008) has an agrifood research background that became shaped by her child's diagnosis with type 1 diabetes in 2013. She is also a passionate diabetes advocate for carers and children with type 1 diabetes, and member of several diabetes Community Advisory Committee’s.

Clinical Associate Professor Craig Taplin is a Consultant Paediatric Endocrinologist at Perth Children's Hospital and the Clinical Lead for the statewide Paediatric Diabetes Service. His clinical and research interests include optimizing diabetes technology outcomes for youth with T1D, and diabetes and exercise.

Aman Pulungan is a Professor of Paediatrics, Senior Consultant in Paediatric Endocrinology, and Project Leader of CDiC Indonesia. He is the immediate past Executive Director of IPA and former president of APPA, APPES, and IPS. For 29 years, he has been involved in diabetes programs across Indonesia and the Asia-Pacific region. As a clinician and researcher, he has published more than 100 scientific articles in international journals and contributed to book chapters. He has received honorary fellowships from TNPA, RCPI, and IAP. He also received the Advocacy and Lifetime Achievement in Pediatrics Award 2024 from EPA/UNEPSA.

Dr Jane Holmes-Walker was employed as a staff specialist in the Dept of Endocrinology, Westmead Hospital in 1998 after completing her training at Westmead Hospital and Middlesex Hospital and University College Hospitals in London. She completed a PhD in the Faculty of Medicine, University of Sydney on 'The A3243G mitochondrial DNA mutation: Contribution to pathogenesis of diabetes mellitus and its complications' awarded in 1999. She has developed a number of new clinical services at Westmead including the Diabetes Transition Support Program for young people with diabetes, The NeuroEndocrine Tumour Service, the Metabolic Bone Disease service and was successful in obtaining long term funding for the Adult Genetic Metabolic Disease service. She is on the ACI committee for Transition which seeks to improve the management of young people with chronic disease and has been involved in the writing of National Guidelines for management of Type I diabetes and Management of Cystic Fibrosis related Diabetes. She has >20 publications in peer reviewed journals.

Ecky is the mother of a child (Ben) diagnosed with Type 1 Diabetes (T1D) in 2023 while her family was living in a regional location in Indonesia, where T1D is not widely understood due to its low prevalence. After returning to Australia in 2024, she gained experience navigating diabetes care across two very different healthcare systems. Through her social media sharing her family's journey, Ecky advocates for greater awareness, support, and connection for families living with T1D, bringing a unique international perspective shaped by lived experience.